Artwork

Content provided by LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 42: Darnisha Harrison - Using Therapeutics to Tackle COVID-19

41:51
 
Share
 

Manage episode 302649926 series 1232128
Content provided by LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
COVID-19 has upended our lives in how we interact and function. As of September 2021, the Centers for Disease Control estimate over 40 million people have been sick and approximately 652,000 people have died in the United States. We see that vaccines and mask-wearing are effective in controlling the spread, but people are still getting sick. We can’t fully eradicate COVID, but what if we could more effectively treat the symptoms of those infected and shorten the duration of their illness? LSU alumna, Darnisha Harrison, the Founder, President & CEO of Ennaid Therapeutics is working to answer that question. In this episode, Darnisha shares the inception of her company and the driving, divine mission to tackle diseases and identify treatments suitable for all of society. Catch more of Darnisha Harrison's story on a previous post on Science Next, "Will it take more than a vaccine to beat the Coronavirus?" Learn about Ennaid Therapeutics: https://ennaidthera.com/
  continue reading

5 episodes

Artwork
iconShare
 
Manage episode 302649926 series 1232128
Content provided by LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by LSU Experimental, LSU Communication across the Curriculum, and LSU College of Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
COVID-19 has upended our lives in how we interact and function. As of September 2021, the Centers for Disease Control estimate over 40 million people have been sick and approximately 652,000 people have died in the United States. We see that vaccines and mask-wearing are effective in controlling the spread, but people are still getting sick. We can’t fully eradicate COVID, but what if we could more effectively treat the symptoms of those infected and shorten the duration of their illness? LSU alumna, Darnisha Harrison, the Founder, President & CEO of Ennaid Therapeutics is working to answer that question. In this episode, Darnisha shares the inception of her company and the driving, divine mission to tackle diseases and identify treatments suitable for all of society. Catch more of Darnisha Harrison's story on a previous post on Science Next, "Will it take more than a vaccine to beat the Coronavirus?" Learn about Ennaid Therapeutics: https://ennaidthera.com/
  continue reading

5 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide